Healthcare

IDT Australia Limited (ASX:IDT)

Industry Group : Pharmaceuticals, Biotechnology & Life Sciences | Industry Group Name : Pharmaceuticals

Market Price : AUD 0.585-0.025 (4.098%)

(as on 2021-12-01 20:56:25 AEDT)

Market Cap : AUD 140.318 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.61 0.615 0.585 0.585L 0.665 H 0.165L 0.755 H
Last Trade 0.585
Change% -4.0984
52 W H/L 0.755/0.165
EBITDA 1.846 M
NPAT After Abnormal Items 2.103 M
Equity 27.615 M
ROE% 7.62%
Total Liabilities 6.514 M
Total Revenue 16.898 M
Cash and Cash Equivalents 6.928 M

Stock Information

Share price 0.585
Market Cap 140.318 M
Price/Gross Cash Flow 32.00
Dividend Yield Excluding Special 0.00%
Ending Shares 239.86 M
52-Week Range 0.755-0.165
P/E ratio 67.568
Sector P/E --
EPS 0.90
EV/EBITDA 26.42
Net Profit Margin (%) 13.12%
Gross Cash Flows Per Share 0.01
Net Gearing -22.31%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 1.480
Net Tangible Asset (NTA) 0.11
Sales Per Share 0.07
Book Value Per Share 0.12

Announcements

Heading Date/Time
IDT Australia 2021 AGM Voting Summary  16/11/2021 12:01PM
IDT Australia 2021 AGM Presentation  16/11/2021 8:30AM
Jobkeeper payments notice  21/10/2021 3:48PM
IDT Australia Notice of AGM 2021  15/10/2021 10:30AM
IDT Australia Limited - Director Retirement  15/10/2021 10:22AM
IDT Executes Manufacturing Agreement With Monash  13/10/2021 10:03AM
Notice received from Regal Funds Management Asia Pte Limited  08/10/2021 3:09PM
IDT Receives Sterile Licence From The TGA  28/09/2021 3:55PM
Notice of Date of Forthcoming AGM and Other Relevant Dates  21/09/2021 11:34AM
IDT Australia Strategy Update  15/09/2021 2:47PM
Supplementary Disclosure - Sterile Readiness Agreement  15/09/2021 2:44PM
Response to ASX Query  08/09/2021 8:39AM
Ceasing to be a substantial holder  27/08/2021 4:08PM
Becoming a substantial holder  25/08/2021 2:51PM
IDT Australia Investor Highlights 2021  25/08/2021 8:59AM
IDT Australia FY21 Annual Report  25/08/2021 8:55AM
IDT Australia Security Trading Policy  25/08/2021 8:50AM
IDT Australia Whistleblower Policy  25/08/2021 8:44AM
IDT Australia Corporate Governance Statement  25/08/2021 8:40AM
IDT Australia Appendix 4G 30 June 2021  25/08/2021 8:36AM
IDT Australia Appendix 4E 30 June 2021  25/08/2021 8:28AM
Media Interest, MIPS COVID-19 Vaccine & Sterile Readiness  23/08/2021 9:46AM
Response to ASX Price Query  19/08/2021 4:26PM
Change in substantial holding  26/07/2021 9:29AM
Ceasing to be a substantial holder  14/07/2021 11:22AM
COVID-19 Vaccine Manufacture discussions with VicGov & MIPS  22/06/2021 2:51PM
IDT Receives 1stCommercialShipment - MedicinalCannabisFlower  22/06/2021 9:49AM
Change in substantial holding  18/06/2021 8:18AM
Change in substantial holding  17/06/2021 8:43AM

Similar Companies

Related Articles

Load More

About Company

IDT Australia Limited (ASX: IDT) is a pharmaceutical company from the HealthCare sector based in Victoria, Australia. The company traces its roots back to 1975 as Institute of Drug Technology Limited (IDT). It is dedicated in high potency manufacture of API and finished dose products, microbiological and analytical testing and pharmacy services. Globally acknowledged pharma companies like Pfizer, Roche, Teva and Bayer are partners of choice for IDT.

Corporate Information

company address 45 Wadhurst Drive, BORONIA, VIC, AUSTRALIA, 3155

company phone(03) 9801 8888

company websitehttp://www.idtaus.com.au/

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 -- 0.000 0.00%
30/06/2012 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-24 2022
Report (Prelim) 2022-08-24 2022
Report (Interim) 2022-02-22 2022

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 16.027 M 14.102 M 11.882 M 12.892 M 9.295 M
Other Revenue 871,000 0 0 292,000 162,000
Total Revenue 16.898 M 14.102 M 11.882 M 13.184 M 9.457 M
Interest Income 29,000 67,000 248,000 171,000 86,000
Interest Expenses 0 0 -24,000 -32,000 -56,000
Expenses -14.181 M -13.381 M -14.35 M -15.129 M -14.589 M
EBITDA 2.717 M 721,000 -2.468 M -1.945 M -5.132 M
Depreciation and Amortization -1.78 M -2.033 M -2.518 M -2.625 M -2.122 M
Depreciation -1.649 M -1.912 M -2.315 M -2.239 M -1.991 M
Amortisation -131,000 -121,000 -203,000 -386,000 -131,000
EBIT 937,000 -1.312 M -4.986 M -4.57 M -7.254 M
Pre Tax Profit 966,000 -1.245 M -4.762 M -4.431 M -7.224 M
Tax Expense 1.137 M 62,000 36,000 1.596 M 343,000
Net Profit After Tax 2.103 M -1.183 M -4.726 M -2.835 M -6.881 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 -736,000 -1.357 M -14.144 M -7.622 M
Reported Net Profit After Abnormal Items 2.103 M -1.919 M -6.083 M -16.979 M -773,000
Ending Shares 239.86 M 239.313 M 236.359 M 244.447 M 248.162 M
Weighted Average Shares 239.321 M 237.118 M 239.464 M 247.83 M 247.607 M
EPS After Abnormal Items (cents) 0.88 -0.81 -2.54 -6.85 -0.31
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 17.266 M 12.813 M 13.419 M 18.952 M 19.405 M
Total Non Current Assets 16.863 M 15.774 M 17.782 M 19.96 M 38.71 M
Total Assets 34.129 M 28.587 M 31.201 M 38.912 M 58.115 M
Total Current Liabilities 6.069 M 4.952 M 4.96 M 4.825 M 5.886 M
Total Non Current Liabilities 445,000 337,000 1.231 M 1.631 M 3.311 M
Total Liabilities 6.514 M 5.289 M 6.191 M 6.456 M 9.197 M
Net Assets 27.615 M 23.298 M 25.01 M 32.456 M 48.918 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash 370,000 -1.888 M -1.516 M -1.627 M 2.019 M
Net Invested Cash -526,000 -761,000 -871,000 7.359 M 2.433 M
Net Financing Cash Flows 224,000 12,000 -2.143 M -122,000 3.944 M
Beginning Cash 6.86 M 9.497 M 14.027 M 8.417 M 21,000
End Cash Position 6.928 M 6.86 M 9.497 M 14.027 M 8.417 M
Exchange Rate Adjustments 0 0 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 6.928 M 6.86 M 9.497 M 14.027 M 8.417 M

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK